We are live on ! Find out more
NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.23B
1-Year Est. Return 81.32%
This Fund
S&P 500
This Quarter Est. Return
-6.2%
1 Year Est. Return
+81.32%
3 Year Est. Return
+192.63%
5 Year Est. Return
+125.03%
10 Year Est. Return
+943.65%
AUM
$2.11B
AUM Growth
+$179M
Cap. Flow
+$345M
Cap. Flow %
16.36%
Top 10 Hldgs %
73.49%
Holding
53
New
4
Increased
8
Reduced
5
Closed
5

Top Buys

Rank Stock Value
1
EXAI
Exscientia Plc American Depositary Shares
EXAI
+$275M
2
BABA icon
Alibaba
BABA
+$41.7M
3
IOBT
IO Biotech
IOBT
+$31.7M
4
UTRS
Minerva Surgical, Inc. Common Stock
UTRS
+$14.6M
5
MQ icon
Marqeta
MQ
+$9.88M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$18.7M
2
BN icon
Brookfield
BN
+$10.1M
3
FLXN
Flexion Therapeutics, Inc.
FLXN
+$8.56M
4
SPNE
SeaSpine Holdings Corporation Common Stock
SPNE
+$3.46M
5
AFIB
Acutus Medical Inc
AFIB
+$2.25M

Sector Composition

Rank Sector Weight
1 Healthcare 56.57%
2 Financials 8.35%
3 Technology 8.08%
4 Consumer Discretionary 2.82%
5 Communication Services 1.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IOVA icon
26
Iovance Biotherapeutics
IOVA
$2.87B
$16M 0.76%
836,518
– –
RCKT icon
27
Rocket Pharmaceuticals
RCKT
$394M
$13.4M 0.63%
612,822
+78,737
+15% +$2.15M
SPNE
28
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$11.7M 0.55%
858,752
-240,726
-22% -$3.46M
GRTX
29
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$11.3M 0.53%
2,459,021
– –
UTRS
30
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
$10.6M 0.5%
+102,857
New +$14.6M
KNTE
31
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$9.8M 0.46%
553,128
+54,600
+11% +$1.15M
TMCI icon
32
Treace Medical Concepts
TMCI
$309M
$9.33M 0.44%
500,421
+216,652
+76% +$4.47M
AKUS
33
DELISTED
Akouos Inc
AKUS
$9.03M 0.43%
1,061,990
+350,045
+49% +$3.14M
INSP icon
34
Inspire Medical Systems
INSP
$1.74B
$8.17M 0.39%
35,500
+14,200
+67% +$3.47M
LUNG icon
35
Pulmonx
LUNG
$87.6M
$7.92M 0.38%
247,047
– –
MQ icon
36
Marqeta
MQ
$1.66B
$7.58M 0.36%
+110,390
New +$9.88M
DMRA
37
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.84B
$7.57M 0.36%
99,912
– –
SPRO icon
38
Spero Therapeutics
SPRO
$73M
$7.51M 0.36%
468,902
– –
PHVS icon
39
Pharvaris
PHVS
$2.44B
$7.43M 0.35%
516,321
+97,378
+23% +$1.52M
ZGNX
40
DELISTED
Zogenix, Inc.
ZGNX
$7.19M 0.34%
442,550
– –
NARI
41
DELISTED
Inari Medical, Inc. Common Stock
NARI
$6.59M 0.31%
72,212
– –
SILK
42
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$6.29M 0.3%
147,557
– –
CMPI
43
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$6.23M 0.29%
2,170,100
– –
VRNA
44
DELISTED
Verona Pharma
VRNA
$5.12M 0.24%
761,205
– –
PRAX icon
45
Praxis Precision Medicines
PRAX
$10.1B
$4.92M 0.23%
16,667
– –
ALNY icon
46
Alnylam Pharmaceuticals
ALNY
$29.3B
$4.24M 0.2%
25,000
– –
AERI
47
DELISTED
Aerie Pharmaceuticals
AERI
$3.9M 0.18%
555,186
– –
FRLN
48
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$3.52M 0.17%
118,441
-10,103
-8% -$413K
ANNX icon
49
Annexon
ANNX
$886M
– –
-114,330
Closed -$2.13M
HRMY icon
50
Harmony Biosciences
HRMY
$2.24B
– –
-40,000
Closed -$1.53M
1
2
3

Similar funds

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
IA
Inspire Advisors Meridian, Idaho $1.23B AUM 18.62% 1-Year Est. Return
HTHT
Hemenway Trust Hemenway Trust Salem, New Hampshire $1.24B AUM 16.52% 1-Year Est. Return
BCP
BlackBarn Capital Partners New York $1.24B AUM 55.98% 1-Year Est. Return
SPC
Stony Point Capital New York $1.24B AUM 32.69% 1-Year Est. Return
SC
Strategy Capital Los Altos, California $1.22B AUM 27.02% 1-Year Est. Return

Novo Holdings A/S's Q4 2021 Portfolio in Review

As of Q4 2021, Novo Holdings A/S held 53 positions worth $2.11B, up 9.2% from $1.93B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Novo Holdings A/S deployed $345M of net new capital in Q4 2021, opening 4 new positions and adding to 8 existing holdings. Its largest new stake was Exscientia Plc American Depositary Shares: 13,086,600 shares worth $259M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 57% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Apple, an estimated $18.7M trimmed.

  • Novo Holdings A/S's largest Q4 2021 buy was Exscientia Plc American Depositary Shares: 13,086,600 shares worth $259M.
  • Novo Holdings A/S added most to Alibaba in Q4 2021, an estimated $41.7M increase.
  • Novo Holdings A/S's biggest Q4 2021 reduction was Apple, cutting an estimated $18.7M.
  • Novo Holdings A/S fully exited Flexion Therapeutics, Inc. in Q4 2021, selling an estimated $8.56M.
  • Novo Holdings A/S's ten largest holdings make up 73% of its $2.11B portfolio in Q4 2021.
  • Novo Holdings A/S opened 4 new positions and closed 5 in Q4 2021.
  • Novo Holdings A/S's portfolio value rose 9.2% quarter-over-quarter to $2.11B.

Based on Novo Holdings A/S's 13F filing for Q4 2021, filed 14 Feb 2022.